Literature DB >> 25678615

Altered mental status: what is the diagnosis?

Arjun Gupta1, William Shelton1, Rajeev Singh1, Ambarish Pandey1.   

Abstract

We report a patient presenting with a 2-day history of altered mental status and lethargy. She had recently started taking prednisone for suspected 'autoimmune arthritis'. Clinical deterioration in hospital characterised by increasing confusion, alternating hyperarousal and somnolence, auditory hallucinations and eventual unresponsiveness led to an intensive care unit transfer. Initial laboratory and radiological testing did not reveal a cause for her symptoms. The only abnormality detected was antithyroid peroxidase antibody levels elevated to >900 IU/mL with patient demonstrating marked clinical improvement within 24 h of receiving high-dose steroids and plasmapheresis. Hashimoto's encephalitis is an underdiagnosed reversible neuropsychiatric disorder with unknown pathogenesis. Recent studies indicate that autoimmune encephalopathy and specifically Hashimoto's encephalitis is under-reported. Our case demonstrates the importance of maintaining a wide differential for altered mental status, especially after negative initial diagnostic work-up of more common aetiologies. Although steroids are an effective treatment for Hashimoto's encephalitis, the addition of early plasmapheresis may be indicated in patients with severe presentation and those who develop disease while taking steroids. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25678615      PMCID: PMC4330425          DOI: 10.1136/bcr-2014-207533

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Hashimoto's encephalopathy responding to plasmapheresis.

Authors:  P M Boers; J G Colebatch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Hashimoto's encephalopathy: response to plasma exchange.

Authors:  Tarun Nagpal; Sanjay Pande
Journal:  Neurol India       Date:  2004-06       Impact factor: 2.117

3.  Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins.

Authors:  S Jacob; Y A Rajabally
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  Hashimoto's encephalopathy: an under diagnosed entity.

Authors:  Anil Bhansali; P Jayaprakash; Pinaki Dutta; Rama Walia; R Anantharaman; M Modi
Journal:  BMJ Case Rep       Date:  2009-05-08

5.  Hashimoto's encephalopathy: a long-lasting remission induced by intravenous immunoglobulins.

Authors:  Jelena Drulović; Sladjana Andrejević; Branka Bonaci-Nikolić; Vesna Mijailović
Journal:  Vojnosanit Pregl       Date:  2011-05       Impact factor: 0.168

6.  Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy.

Authors:  Rodrigo Cornejo; Pablo Venegas; Daniela Goñi; Alvaro Salas; Carlos Romero
Journal:  BMJ Case Rep       Date:  2010-12-29

Review 7.  Autoimmune encephalopathy.

Authors:  Eoin P Flanagan; Richard J Caselli
Journal:  Semin Neurol       Date:  2011-05-17       Impact factor: 3.420

Review 8.  Autoimmune encephalopathies.

Authors:  Steven Vernino; Michael Geschwind; Bradley Boeve
Journal:  Neurologist       Date:  2007-05       Impact factor: 1.398

9.  Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes.

Authors:  Stéphanie Blanchin; Christine Coffin; Fausto Viader; Jean Ruf; Pierre Carayon; Francette Potier; Estelle Portier; Elisabeth Comby; Stéphane Allouche; Yann Ollivier; Yves Reznik; Jean Jacques Ballet
Journal:  J Neuroimmunol       Date:  2007-10-26       Impact factor: 3.478

10.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

Authors:  Pablo Castillo; Bryan Woodruff; Richard Caselli; Steven Vernino; Claudia Lucchinetti; Jerry Swanson; John Noseworthy; Allen Aksamit; Jonathan Carter; Joseph Sirven; Gene Hunder; Vahab Fatourechi; Bahram Mokri; Daniel Drubach; Sean Pittock; Vanda Lennon; Brad Boeve
Journal:  Arch Neurol       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.